Working... Menu

Imiquimod/Brain Tumor Initiating Cell (BTIC) Vaccine in Brain Stem Glioma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01400672
Recruitment Status : Suspended (Pending review.)
First Posted : July 22, 2011
Last Update Posted : February 15, 2019
Information provided by (Responsible Party):
Masonic Cancer Center, University of Minnesota

No Study Results Posted on for this Study
  Recruitment Status : Suspended
  Actual Primary Completion Date : March 7, 2016
  Estimated Study Completion Date : October 10, 2019